Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A genetic engineering toolkit for the probiotic yeast Saccharomyces boulardii.

Created on 16 Nov 2026

Authors

Huaming Dong, Chunqiao Xiao, Yanfei Zhang

Published in

Synthetic and systems biotechnology. Volume 19. Pages 155-163. Epub Nov 10, 2026.

Abstract

Saccharomyces boulardii (S. boulardii) is the only yeast probiotic widely used in clinical practice and consumer products. It combines gastrointestinal robustness, intrinsic antibiotic tolerance and eukaryotic protein-processing capacity, making it an attractive chassis for engineered probiotics, in situ biomanufacturing and live biotherapeutic delivery. However, host-specific characterization of regulatory elements, candidate genomic integration sites, and multicopy integration strategies remains limited in the clinically used S. boulardii CNCM I-745 background. Here, using S. boulardii CNCM I-745 as the host, we developed and characterized a genetic engineering toolkit that integrates transcriptional control elements with genome-integration strategies. We first quantified the activities of 20 endogenous constitutive promoters, two inducible promoters and six terminators. We then established a markerless CRISPR-Cas9 workflow and evaluated 10 chromosomal integration loci; six of which showed Editing efficiency above 80% while supporting comparable transgene expression without detectable growth penalties. Finally, we constructed an rDNA-repeat-based multicopy integration system that increased transgene expression by 9.8- to 22.6-fold relative to single-copy integration and revealed a significant positive but non-proportional association between estimated copy number and reporter output. Together, this toolkit provides S. boulardii with a set of tunable promoters and terminators, candidate chromosomal integration sites compatible with a markerless CRISPR-Cas9 workflow. These resources expand the genetic accessibility of this probiotic yeast and provide a foundation for developing engineered S. boulardii strains with enhanced probiotic, therapeutic and biomanufacturing functions.

PMID:
43036820
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement